Videos

Considerations for the role of patient advocacy groups and patient-to-patient education in the differentiated thyroid cancer journey.

Watch Dr. Sham Mailankody, from Memorial Sloan Kettering Cancer Center, discuss CAR and BiTE therapy, during the CURE Educated Patient Multiple Myeloma Summit.

Watch Dr. Saad Z. Usmani, Dr. Ben Marcus and Stan Wagner discuss their participation in the Moving Mountains for Multiple Myeloma program, during the CURE Educated Patient Multiple Myeloma Summit.

Watch Kristie L. Kahl, Donna and Jack McNutt, Dr. Noopur Raje, and Grace Allison, discuss treating myeloma long term, during the CURE Educated Patient Multiple Myeloma Summit.

Sophie Mueller provides advice for patients and caregivers with breast cancer who may be in similar situations.

Watch Dr. Saad Z. Usmani, Dr. Krina K. Patel, Dr. Noa Biran, and Jenny Ahlstrom, answer audience Q&A during the CURE Educated Patient Multiple Myeloma Summit.

Watch Dr. Noa Biran, an associate professor of medicine in the division of multiple myeloma at The John Theurer Cancer Center at Hackensack University Medical Center, discuss treatment for relapsed/refractory myeloma.

Watch Dr. Krina K. Patel, an associate professor and center medical director for the Department of Lymphoma-Myeloma at The University of Texas MD Anderson Cancer Center discuss treatment for newly diagnosed myeloma.

In CURE’s Speaking Out video series, on behalf of Living Beyond Breast Cancer, Andrea Kassem discusses integrative care in metastatic breast cancer.

In CURE’s Speaking Out video series, on behalf of Living Beyond Breast Cancer, Dr. Nancy Lin discusses treatment planning for patients with breast cancer that has metastasized to the brain.

In CURE’s Speaking Out video series, on behalf of Living Beyond Breast Cancer, Myra Camino discusses her experience as a patient advocating for herself after her stage 4 metastatic breast cancer diagnosis.

In CURE’s Speaking Out video series, on behalf of Living Beyond Breast Cancer, Dr. Nancy Lin discusses the multidisciplinary approach to metastatic breast cancer care.

Watch Saad Z. Usmani, MD, MBA, with Carlyn Rose Tan, MD; Neha S. Korde, MD; and Kenny Capps answer audience Q&A during the CURE Educated Patient Multiple Myeloma Summit.

Expert perspectives on the broad management of differentiated thyroid cancer, including surgery, radiation treatment, and systemic therapy.

Health care specialists provide an overview on the nature of differentiated thyroid cancer and discuss subtypes of disease that patients may present with.

Watch Dr. Carlyn Rose Tan, an assistant attending in myeloma service at Memorial Sloan Kettering Cancer Center, present on risk stratification for newly diagnosed patients.

Learn about the disproportionate impact that the COVID-19 pandemic has on immunocompromised patients with chronic lymphocytic leukemia (CLL), and hear potential solutions from leading CLL experts.

Watch Dr. Neha S. Korde, an assistant professor in multiple myeloma service in the Division of Hematology at Memorial Sloan Kettering Cancer Center, present on MGUS/smoldering myeloma.

Patient Meryl Uranga describes how she was diagnosed with metastatic clear cell renal cell carcinoma and the initial treatments she received.

Chung-Han Lee, M.D., provides background on clear cell renal cell carcinoma, including common symptoms and risk factors.

Cancer survivors may often struggle with talking about their fear of recurrence with loved ones, which is why one expert recommends they seek solace in support groups.

When lovers of “Pinky and the Brain,” “Teenage Mutant Ninja Turtles” and other cartoons gathered in voice actor Rob Paulsen’s hospital room, he took particular notice of one exuberant woman with cancer who was extroverted and kind, despite not having long to live.

It is essential that patients and providers discuss appropriate options for maintenance therapy after ovarian cancer, one expert explained.

Sophie Mueller, Jocelyn’s daughter and caregiver, explains her perspectives as a caregiver to Jocelyn and how that impacted her life.

Jocelyn Mueller details her experience with her caregiver and the describes the support she received from her community as she continues her journey.

Jocelyn Mueller describes the treatment process with sub-cutaneous HER2-targeting therapy post-operatively and some of the adjustments that she made to her daily life.

Jocelyn Mueller, a patient with HER2-postive breast cancer, explains the recovery process after surgery and the impact that the availability sub-cutaneous HER2-targeting therapy has had on her breast cancer journey.

As the average price of regular-grade gas in the United States speeds past $4.30 a gallon, many patients with cancer may be wondering how they can afford to get to and from cancer treatments. Luckily, there’s assistance to make travel less expensive.

Unlike stem cell transplant, which has strict eligibility criteria, the majority of patients with blood cancer may be able to receive CAR-T cell therapy, regardless of other comorbidities, explained an expert.

Despite several FDA drug approvals over the past few years in the cholangiocarcinoma space, many patients are ineligible for these treatments as a first option, signaling a significant unmet need.